Systemic activation of basophils and eosinophils: Markers and consequences
- 1 November 2000
- journal article
- review article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 106 (5), S292-S302
- https://doi.org/10.1067/mai.2000.110164
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Molecular pathology of allergic disease: I: Lower airway diseaseJournal of Allergy and Clinical Immunology, 2000
- Abnormal Clones of T Cells Producing Interleukin-5 in Idiopathic EosinophiliaNew England Journal of Medicine, 1999
- αdβ2 Integrin Is Expressed on Human Eosinophils and Functions as an Alternative Ligand for Vascular Cell Adhesion Molecule 1 (VCAM-1)The Journal of Experimental Medicine, 1998
- Lyn, Jak2, and Raf-1 Kinases Are Critical for the Antiapoptotic Effect of Interleukin 5, whereas only Raf-1 Kinase Is Essential for Eosinophil Activation and DegranulationThe Journal of Experimental Medicine, 1998
- Function and expression of adhesion molecules on human basophilsJournal of Allergy and Clinical Immunology, 1994
- Pulmonary function, activated T cells, peripheral blood eosinophilia, and serum activity for eosinophil survival in vitro: A longitudinal study in bronchial asthmaJournal of Allergy and Clinical Immunology, 1994
- CC chemokines in allergic inflammationImmunology Today, 1994
- Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitisBritish Journal of Dermatology, 1992
- Spontaneous Release of Histamine from Basophils and Histamine-Releasing Factor in Patients with Atopic Dermatitis and Food HypersensitivityNew England Journal of Medicine, 1989
- Human Basophil Releasability. II. Changes in Basophil Releasability in Patients with Atopic DermatitisJournal of Investigative Dermatology, 1986